» Articles » PMID: 7543761

Prolonged Alteration of Vasoconstrictor and Vasodilator Responses in Rat Knee Joints by Adjuvant Monoarthritis

Overview
Journal Exp Physiol
Specialty Physiology
Date 1995 May 1
PMID 7543761
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Both neurogenic influences and the regulatory neuropeptide substance P (SP) have been implicated in the development of joint inflammation. Using the laser Doppler perfusion imaging technique to quantify relative changes in joint blood flow, the effects of nerve stimulation and topical SP application were examined in normal and chronically inflamed rat knee joints. Synovial inflammation was induced by unilateral intra-articular injection of Freund's complete adjuvant and experiments were carried out 1 week and 3 weeks later. Normal knees showed a frequency-dependent vasoconstriction in response to saphenous nerve stimulation over the range of 5-30 Hz and a dose-dependent vasodilation in response to SP administration. These vasoactive responses were completely abolished in the chronically inflamed knee joint, the abolition persisting throughout the investigation. Since articular cartilage is critically dependent on synovial fluid formation for its nutrition, loss of neurovascular control of the synovial microcirculation could contribute to the degenerative changes that commonly accompany chronic inflammatory joint diseases.

Citing Articles

Hematological Response to Particle Debris Generated During Wear-Corrosion Processes of CoCr Surfaces Modified with Graphene Oxide and Hyaluronic Acid for Joint Prostheses.

Escudero M, Garcia-Alonso M, Chico B, Lozano R, Sanchez-Lopez L, Flores-Saenz M Nanomaterials (Basel). 2024; 14(22).

PMID: 39591056 PMC: 11597578. DOI: 10.3390/nano14221815.


Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis.

Liao Z, Umar M, Huang X, Qin L, Xiao G, Chen Y Cell Prolif. 2023; 57(3):e13569.

PMID: 37994506 PMC: 10905355. DOI: 10.1111/cpr.13569.


Osteoarthritis is a neurological disease - an hypothesis.

McDougall J Osteoarthr Cartil Open. 2022; 1(1-2):100005.

PMID: 36474723 PMC: 9718286. DOI: 10.1016/j.ocarto.2019.100005.


Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis.

Cruz C, Dewberry L, Otto K, Allen K Curr Rheumatol Rep. 2022; 25(1):1-11.

PMID: 36435890 PMC: 11438129. DOI: 10.1007/s11926-022-01094-2.


Cannabinoid control of neurogenic inflammation.

McKenna M, McDougall J Br J Pharmacol. 2020; 177(19):4386-4399.

PMID: 33289534 PMC: 7484507. DOI: 10.1111/bph.15208.